Our study reveals that TP53/miR‐3647‐5p/AGR2 axis inhibits the proliferation of cervical cancer cells and promotes apoptosis, providing a new strategy for targeted therapy of cervical cancer. The gene discussed is TP53; the disease is cervical carcinoma.